IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1

S100A8/9 and S100A12 are emerging biomarkers for disease activity of autoimmune and cardiovascular diseases. We demonstrated previously that S100A12 accelerates atherosclerosis accompanied by large cholesterol deposits in atherosclerotic lesions of apoE-null mice. The objective of this study was to ascertain whether S100/calgranulin influences cholesterol homeostasis in macrophages. Peritoneal macrophages from transgenic mice expressing human S100A8/9 and S100A12 in myeloid cells [human bacterial artificial chromosome (hBAC)/S100] have increased lipid content and reduced ABCG1 expression and [3H]cholesterol efflux compared with WT littermates. This was associated with a 6-fold increase in plasma interleukin (IL)-22 and increased IL-22 mRNA in splenic T cells. These findings are mediated by the receptor for advanced glycation endproducts (RAGE), because hBAC/S100 mice lacking RAGE had normal IL-22 expression and normal cholesterol efflux. In vitro, recombinant IL-22 reduced ABCG1 expression and [3H]cholesterol efflux in THP-1 macrophages, while recombinant S100A12 had no effect on ABCG1 expression. In conclusion, S100/calgranulin has no direct effect on cholesterol efflux in macrophages, but rather promotes the secretion of IL-22, which then directly reduces cholesterol efflux in macrophages by decreasing the expression of ABCG1.

[1]  Richard G. W. Anderson,et al.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins , 1979, The Journal of cell biology.

[2]  K. Aziz,et al.  Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. , 2009, The American journal of cardiology.

[3]  Gene Kim,et al.  Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. , 2013, Atherosclerosis.

[4]  J. Meephansan,et al.  Effect of methotrexate on serum levels of IL-22 in patients with psoriasis. , 2011, European journal of dermatology : EJD.

[5]  G. Abela.  Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. , 2010, Journal of clinical lipidology.

[6]  Gene Kim,et al.  S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm , 2010, Circulation research.

[7]  D. S. Lin,et al.  Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. , 1983, Journal of lipid research.

[8]  J. Carucci,et al.  Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.

[9]  D. Foell,et al.  Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4. , 2013, American journal of respiratory and critical care medicine.

[10]  K. Asadullah,et al.  IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.

[11]  M. Bond,et al.  Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. , 1984, The Journal of clinical investigation.

[12]  P. Libby,et al.  Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006, Circulation.

[13]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[14]  V. Babaev,et al.  Atherosclerotic lesions of apolipoprotein E deficient mice contain cells expressing S100 protein. , 1999, Atherosclerosis.

[15]  P. Subbaiah,et al.  Effects of Apolipoprotein A-I on ATP-binding Cassette Transporter A1-mediated Efflux of Macrophage Phospholipid and Cholesterol , 2003, Journal of Biological Chemistry.

[16]  F. Morel,et al.  A role for T cell‐derived interleukin 22 in psoriatic skin inflammation , 2007, Clinical and experimental immunology.

[17]  Jihong Han,et al.  Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36* , 1997, The Journal of Biological Chemistry.

[18]  B. Porse,et al.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. , 2008, CSH protocols.

[19]  P. Ridker,et al.  AJC editor's consensus: psoriasis and coronary artery disease. , 2008, The American journal of cardiology.

[20]  K. Herold,et al.  RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation1 , 2008, The Journal of Immunology.

[21]  Ira Tabas,et al.  Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. , 2002, The Journal of clinical investigation.

[22]  Tony S. Tao,et al.  Proinflammatory properties of the human S100 protein S100A12 , 2001, Journal of leukocyte biology.

[23]  R. Ramasamy,et al.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. , 2010, Circulation research.

[24]  M. Brown,et al.  Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. , 1980, Journal of lipid research.

[25]  R. Virmani,et al.  Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics: A Postmortem Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  K. Bornfeldt,et al.  S100A8 and S100A9 in cardiovascular biology and disease. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[27]  B Lundberg,et al.  Chemical composition and physical state of lipid deposits in atherosclerosis. , 1985, Atherosclerosis.

[28]  A. Tall,et al.  Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.

[29]  H. Volk,et al.  IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not , 2009, Journal of Molecular Medicine.

[30]  Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006 .

[31]  Guoliang Cui,et al.  Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. , 2011, The Journal of clinical investigation.

[32]  S. Galdino,et al.  Increased Serum Interleukin 22 in Patients with Rheumatoid Arthritis and Correlation with Disease Activity , 2012, The Journal of Rheumatology.

[33]  M. Reilly,et al.  Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. , 2012, Atherosclerosis.

[34]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[35]  K. Herold,et al.  RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses , 2012, PloS one.

[36]  R. Flavell,et al.  Recent advances in IL-22 biology. , 2011, International immunology.

[37]  K. Aziz,et al.  Cholesterol crystals cause mechanical damage to biological membranes: A proposed mechanism of plaque rupture and erosion leading to arterial thrombosis , 2005, Clinical cardiology.

[38]  E. Fitzke,et al.  Differences in the state of differentiation of THP‐1 cells induced by phorbol ester and 1,25‐dihydroxyvitamin D3 , 1996, Journal of leukocyte biology.

[39]  Gene Kim,et al.  S100A12 in Vascular Smooth Muscle Accelerates Vascular Calcification in Apolipoprotein E–Null Mice by Activating an Osteogenic Gene Regulatory Program , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[40]  O Fitzgerald,et al.  Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. , 2003, Rheumatology.

[41]  P. Libby,et al.  Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. , 2008, American heart journal.

[42]  S. Kaneko,et al.  Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein , 2006, Mediators of inflammation.

[43]  F. Berger,et al.  Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. , 2010, Rheumatology.

[44]  J. Renauld,et al.  Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. , 2009, Arthritis and rheumatism.

[45]  K. Gaus,et al.  Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages , 2006, Current opinion in lipidology.

[46]  D. Foell,et al.  Carboxylated N‐glycans on RAGE promote S100A12 binding and signaling , 2010, Journal of cellular biochemistry.

[47]  S. Zheng,et al.  Emerging role of interleukin-22 in autoimmune diseases. , 2013, Cytokine & growth factor reviews.

[48]  J. Kolls,et al.  Cytokine-mediated regulation of antimicrobial proteins , 2008, Nature Reviews Immunology.

[49]  I. Lednev,et al.  Hexameric Calgranulin C (S100A12) Binds to the Receptor for Advanced Glycated End Products (RAGE) Using Symmetric Hydrophobic Target-binding Patches* , 2006, Journal of Biological Chemistry.